A Study of LY3848575 in Healthy Participants

NCT05727072 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3848575
DRUG: LY3848575
DRUG: Placebo
DRUG: Placebo

Sponsor

Eli Lilly and Company